Concepedia

Yu Zhu

YZ

Statistics

Publications

15

Citations

379

H-Index

12

Active since

2008

Affiliations

Nanjing Medical University(Current)

Jiangsu Province Hospital

State Key Laboratory of Natural Medicine

China Pharmaceutical University

Nanjing Drum Tower Hospital

Yu Zhu is an author at Nanjing Medical University specializing in oncology, molecular oncology, and medicine.

Publications per year

2008–2024

15

Publications

15

Efficacy and safety of decitabine in combination with G-CSF, low-dose cytarabine and aclarubicin in newly diagnosed elderly patients with acute myeloid leukemia

Jianyong Li, Yaoyu Chen, Yu Zhu et al. · Oncotarget · 2015 · 62 citations · Full text

, , +17

TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia

Sixuan Qian, Jianyong Li, Ming Hong et al. · Journal of Hematology & Oncology · 2016 · 52 citations · Full text

, , +17

Wogonin induces cell cycle arrest and erythroid differentiation in imatinib-resistant K562 cells and primary CML cells

Hao Yang, Hui Hui, Qian Wang et al. · Oncotarget · 2014 · 40 citations · Full text

, , +17

Effects of chidamide and its combination with decitabine on proliferation and apoptosis of leukemia cell lines.

Jianping Mao, Shan Li, Huihui Zhao et al. · PubMed · 2018 · 36 citations · Full text

, , +15

Decitabine in combination with low-dose cytarabine, aclarubicin and G-CSF tends to improve prognosis in elderly patients with high-risk AML

Ming Hong, Han Zhu, Qian Sun et al. · Aging · 2020 · 30 citations · Full text

, , +14

1–5 of 15